NCT07433933已完成不适用
Clinical Study to Evaluate the Efficacy and Safety of a Cosmetic Product in Subjects With Telogen Effluvium and Androgenic Alopecia
Lacer S.A.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年5月12日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Change in hair lenght and thickness
研究概览
简要总结
The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia (AGA). The main question it aims to answer is:
• Does a shampoo use help to reduce the visible signs of hair loss related to TE and AGA?
Subjects will use the shampoo for 3 months and visit the clinic for the visits established by the protocol.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Sex: Both (50% women; 50% men).
- •Age: 18-65 years.
- •Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio.
- •Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men.
- •Telogen effluvium: Combing test.
- •Subjects with all hair types (oily, combination, sensitive, etc.).
- •Subjects with all scalp types (normal, sensitive, etc.).
- •Agree to participate voluntarily in the study and provide written informed consent.
- •Adequate level of understanding of the clinical study.
- •Good health (physical and mental).
- •Availability to attend visits to the research centres.
- •No application of any product to the experimental area on the first day of the trial.
排除标准
- •Individuals under 18 years of age.
- •Pregnant or breastfeeding women.
- •Injuries or infection in the test area.
- •History of allergies to cosmetic products.
- •Known allergies to product components.
- •Sensitivity to any product component.
- •Patients who have undergone recent surgery or treatments in the study area.
- •Cancer patients.
- •Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study.
- •Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at least 6 months.
- •Hair cutting or dyeing during the study.
- •Health problems, to be assessed by the specialist, that may compromise adherence to the study protocol.
研究组 & 干预措施
anti-hair loss shampoo
干预措施: anti-hair loss shampoo (Other)
结局指标
主要结局
Change in hair lenght and thickness
时间窗: From baseline to the end of use at 3 months.
次要结局
- Change in hair lenght and thickness at 1 month(Baseline and 1 month of use)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Olistic_2025 for Hair Loss, Hair Growth, and Skin ImprovementNCT07300813Bionos Biotech S.L.100
已完成
不适用
Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 WeeksNCT07292467Vichy Laboratoires40
进行中（未招募）
不适用
Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human VolunteersNCT07347145Olistic Research Labs S.L.60
已完成
不适用
Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human VolunteersNCT07300228Olistic Research Labs S.L.39
已完成
不适用
To study the effect of Mintop shampoo in women with hairfallCTRI/2022/06/043355Dr Reddys Laboratories Ltd165